Concepedia

Harry Leider

HL

Statistics

Publications

6

Citations

362

H-Index

6

Active since

1999

Affiliations

Thomas Jefferson University(Current)

Acerinox (Spain)

Medical Decision Logic

Harry Leider is an author at Thomas Jefferson University specializing in urine opioid testing, urine drug screening, and pharmacology.

Publications per year

1999–2018

6

Publications

6

A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss

Frank L. Greenway, Louis J. Aronne, Anne Raben et al. · Obesity · 2018 · 176 citations · Full text

, , +17

Healthcare costs and nonadherence among chronic opioid users.

Harry Leider, Jatinder Dhaliwal, Elizabeth J. Davis et al. · PubMed · 2011 · 80 citations

, , +14

High Rates of Inappropriate Drug Use in the Chronic Pain Population

Joseph Couto, Martha Romney, Harry Leider et al. · Population Health Management · 2009 · 68 citations

, , +15

Use of an algorithm applied to urine drug screening to assess adherence to an OxyContin® regimen

Joseph Couto, Lynn R. Webster, Martha Romney et al. · Journal of Opioid Management · 2018 · 17 citations

, , +16

Gaining Physician Buy-In for Disease Management Initiatives

Harry Leider · Disease Management & Health Outcomes · 1999 · 11 citations

, , +8

1–5 of 6